EP
LLY icon

Essential Partners’s Eli Lilly LLY Stock Holding History

Essential Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$445K Buy
371
+78
+27% +$79.7K 0.21% 88
2026
Q1 		$270K Buy
293
+71
+32% +$72K 0.09% 239
2025
Q4 		$239K Buy
222
+41
+23% +$39.2K 0.07% 287
2025
Q3 		$138K Buy
181
+86
+91% +$64K 0.05% 382
2025
Q2 		$74.1K Buy
+95
New +$73.8K 0.03% 394

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Essential Partners's LLY Position: Q2 2026 in Review

Essential Partners increased its Eli Lilly (LLY) stake by 27% in Q2 2026, buying an estimated $79.7K and bringing the position to 371 shares worth $445K. The position accounts for 0.21% of the portfolio, ranked #88.

Essential Partners first reported a position in LLY in Q2 2025 and has held it in 5 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Essential Partners held 371 shares of Eli Lilly worth $445K as of Q2 2026.
  • Essential Partners bought 78 Eli Lilly shares in Q2 2026, an estimated $79.7K.
  • Eli Lilly made up 0.21% of Essential Partners's portfolio in Q2 2026, its #88 holding.
  • Essential Partners first reported a position in Eli Lilly in Q2 2025 and has held it in 5 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.